PaxMedica Inc. Common Stock (PXMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    PaxMedica Inc. Common Sto...

    OTC: PXMD · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Mar 18, 2025, 2:54 PM

    PaxMedica Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -16.15M -10.6M -7.2M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -18.29M -14.8M -10.23M
    Net Income
    		 -18.29M -14.8M -13.03M
    Selling & General & Admin
    		 12.23M 8.82M 4.97M
    Research & Development
    		 3.91M 1.79M 2.22M
    Other Expenses
    		 n/a -5.51M 173.35K
    Operating Expenses
    		 16.15M 10.6M 7.2M
    Interest Expense
    		 9.16K 5.24K 2.81M
    Selling & Marketing Expenses
    		 -12.22B n/a n/a
    Cost & Expenses
    		 16.15M 10.6M 7.2M
    Income Tax Expense
    		 n/a 4.19M 2.81M
    Shares Outstanding (Basic)
    		 1.66M 514.22K 692.91K
    Shares Outstanding (Diluted)
    		 1.66M 514.22K 692.91K
    EPS (Basic)
    		 -11 -28.79 -18.81
    EPS (Diluted)
    		 -11 -28.79 -18.81
    EBITDA
    		 -16.15M -10.6M -7.2M
    EBIT
    		 -18.28M -14.4M -7.42M
    Depreciation & Amortization
    		 167.9K -5.9M 173.35K

    Add to Watchlist